Clinical Trial Update: Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial comparing bone marrow mononuclear cells to mesenchymal stem cells in diabetic patients with chronic limb-threatening ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Limb-threatening Ischemia

Drugs mentioned

• Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)
• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | Conditions: Chronic Limb-threatening Ischemia, Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED